Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지

Effects if Benzo(a)pyrene on Natural Killer Cell Activity of Mice

Benzo(a)pyrene이 마우스 자연살해세포 활설에 미치는 영향

  • Oh, Dong-Il ;
  • Kim, Kwang-Hyuk ;
  • Lee, Chung-Han ;
  • Chung, Hyun-Kee ;
  • Park, Jae-Sun ;
  • 오동일 (고신대학교 의학부 미생물학교실) ;
  • 김광혁 (고신대학교 의학부 미생물학교실) ;
  • 이충환 (고신대학교 외과학교실) ;
  • 정현기 (고신대학교 소아과학교실) ;
  • 박재선 (고신대학교 소아과학교실) ;
  • 장명웅 (고신대학교 의학부 미생물학교실)
  • Published : 1998.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Benzo(a)pyrene(B(a)P), an extensively studied polycyclic aromatic hydrocarbon(PAH), is a common contaminant produced through the burning of fossil fuels, particularly coal, and from the exhaust products of internal combustion engines. It produces a wide range of toxicities, including carcinogenicity in experimental animals. B(a)P has been shown to suppress systemic immunity in experimental animals, which may contribute to the growth of the chemical-induced tumors. Using colorimetric MTT assay natural killer(NK) cell-mediated growth inhibition of tomor cell was measured in normal and B(a)P-exposed C57BL/6 mice. Non-adherent splenocytes of normal or B(a)P-exposed mice were cultured with Yac-1 cells at four different effector/target(E/T) cell ratios ranging from 200/1, 100/1, 50/1, and 25/1 in an assay volume of 0.1 ml. After the optical density of culture wells containing MTT solution was measured at a wavelength of 540 nm, the percentage of dead cells relative to the control target cell number was calculated. The NK activity of B(a)P-exposed mice was markedly lower than that of non-exposed mice group at all E/T ratios. These results indicated that suppression of NK cell activity may play a role in allowing for the growth of tumors.

발암물질인 benzo(a)pyrene(B(a)P)이 암세포에 대한 세포성 방어능을 나타내는 자연살해(natural killer(NK))세포 활성에 미치는 영향을 관찰하기 위하여 사료를 C57BL/6마우스에 노출시킨 후 NK세포활성을 MTT시험법을 이용하여 측정하였다. 정상 및 시료노출군 마우스의 NK세포활성은 표적세포인 Yac-1세포에 대한 사멸세포백분율(percent dead cell)로서 측정하였다. 정상마우스의 비장세포에 B(a)P를 노출시켰을 때 노출군들은 시료농도에 따른 활성도에 큰 변화는 없었으니 낮은 농도($2.5^{\mu}g/ml$)의 노출에서도 정상에 비하여 현격히 낮은 활성치를 보였다. 정상마우스에 시료를 투여한 후에 분리한 비장세포의 NK세포활성치는 E/T ratio 200/1에서, 1회 투여보다는 2-3회 투여군에서 유의한 감소를 나타냄으로서 반복노출의 효과를 보였다. 본 시험을 통하여 B(a)P는 마우스 면역계에 미치는 효과중 암형성에 지대한 영향을 주는 NK세포활성을 크게 저하시킴을 알 수 있었다.

Keywords

References

  1. 대한의학협회지 v.24 한국정상인 말초혈액 림파구의 Natural Killer(NK)활성치에 관한 연구 하윤문;김광혁;전무형;우종설;임수덕
  2. Adv Immunol. v.47 Biology of natural killer cells Trincheri G.
  3. Clin. Immunol. Immunopathol. v.19 Distribution of natural killer activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro with interferon preparation Antonelli P.;Stewart Ⅱ W.;Dupont B.
  4. Br. J. Cancer v.6 Intensity of class I antigen expression on hyman cell lines and its relevance to the efficiency of non-MHC-restricted killing Nouri A. M. E.;Hussain R. F.;Dos santos A. V. L.
  5. J. Immunol. Methods. v.180 Super-sensitive eqithelial cell line and colorimetric assay to replace the conventional K562 target and chromium releae assay for assement of non-MHC-restricted cytotoxicity Nouri A. M. E.;Mansorui M.;Hussain R. F.;Dos Santos a. V. L.;Oliver R. T. D.
  6. Cancer Res. v.48 Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphoctes Anderson T. M.;Ibayashi Y.;Tokida Y.;Colquhoun S. D.;Carmack E.;Colub S. H.
  7. Immunol. Today v.10 The cytokine network Balkwill F. R.;Burke F.
  8. Nature v.273 Enhanced NK cell activity in mice injected with interferon and interferon inducers Gidlund M.;Orn A.;Wigzell H.;Senik A.;Gresser I
  9. J. Exp. Med. v.155 Lymphokine-activated killer cell phenomenon : Lysis of natural killer-resistent fresh solid tumor cells by interleukin 2-activated autologous hyman peripheral blood lymphocytes Grimm E. A.;Mazumder A.;Zhang H. Z.;Rosenberg S. A.
  10. J. Immunol. v.126 In vitro augmentation of rat natural killer cell activity Reynolds C. W.;Herberman R. B.
  11. J. Immunol. v.138 Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1 : Reduction in host defence against malignancy without loss of cellular of humoral immunity Seaman W. E.;Sleisenger M.;Eriksson E.;Koo G. C.
  12. Br. J. Haematol. v.77 Inducibility of lymphokine activated killer(LAK) cells in patients with myelogenous leukemia in complete remission and its clinical relevance Archimbaud E.;Bally M.;Dore J.
  13. J. Immunol. v.140 Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells Fries R. U.;Golub SH
  14. Cell. Immunol. v.94 The human lymphokine-activated killer cell system : V. Purified recombinant interleukin-2 activated cytotoxic lymphocytes which lyse both natural killer-resistant autologous and tumors and thitrophenyl-modified autologous peripheral blood lymphocytes Grim E. A.;Wilson D. J.
  15. Toxicol. Appl. Pharmacol. v.116 Evaluation of murine splenic cell type metabolism of benzo(a)pyrene and functionality in vitro following repeated in vivo exposure to benzo(a)pyrene Ladics g. S.;Kawabata T. T.;Munson A. E.;White KL Jr
  16. Toxicol. v.31 Immunocytotoxicity effects of polycyclic aromatic hydrocarbons on mouse lymphocytes Wojdani A.;Attarzadeh M.;Woldetsadik G.;Alfred LJ
  17. Cancer Res. v.46 Immunomodulation by polyaromatic hydrocarbons in mice and murine cells Blanton R. H.;Lyte M.;Myers M. J.;Bick P. H.
  18. Clin. Exp. Immunol. v.52 Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice Dean J. H.;Luster M. I.;Boorman G. A.;Lauer L. D.;Leubke R. W.;Lawson L.
  19. J. Natl. Cancer Inst. v.36 Effectsof noncarcinogenic and carcinogenic hydrocarbons on antibody-forming cells measured at the cellular level in vitro Stjernsward J.
  20. Selected methods in cellular immunology(1st ed.) Mishell B. B.;Shiigi S. M.
  21. J. Immunol. Methods v.170 Evaluation of the MTT and SRB assays for testing LAK cellmediated growth inhibition of various adherent and non-adherent tumor target cells Garbin F.;Eckert K.;Maurer H. R.
  22. J. Immunol. Methods v.160 A new approach for measurement of cytotoxicity using colormetric assay Hussain R. F.;Nouri A. M. E.;Oliver R. T. D.
  23. J. Immunol. Methods v.65 Rapid colorimetric assay for cellular growth and survival : Application to proliferation and cytotoxic assays Mosmann T.
  24. J. Pharmacol. Exp. Ther. v.242 Mechanisms of benzo(a)pyrene-induced modulation of antigen presentation Myers M. J.;Schook L. B.;Bick P. H.
  25. Cancer Res. v.44 Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not the noncarcinogenic congener benzo(a)pyene White K. L.;Holsapple M. P.